APA

Holzer P., Masuya K., Furet P., Kallen J., Valat-Stachyra T., Ferretti S., Berghausen J., Bouisset-Leonard M., Buschmann N., Pissot-Soldermann C., Rynn C., Ruetz S., Stutz S., Chène P., Jeay S. & Gessier F. (20151116). Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors. : Journal of medicinal chemistry.

Chicago

Holzer Philipp, Masuya Keiichi, Furet Pascal, Kallen Joerg, Valat-Stachyra Therese, Ferretti Stéphane, Berghausen Joerg, Bouisset-Leonard Michèle, Buschmann Nicole, Pissot-Soldermann Carole, Rynn Caroline, Ruetz Stephan, Stutz Stefan, Chène Patrick, Jeay Sébastien and Gessier Francois. 20151116. Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors. : Journal of medicinal chemistry.

Harvard

Holzer P., Masuya K., Furet P., Kallen J., Valat-Stachyra T., Ferretti S., Berghausen J., Bouisset-Leonard M., Buschmann N., Pissot-Soldermann C., Rynn C., Ruetz S., Stutz S., Chène P., Jeay S. and Gessier F. (20151116). Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors. : Journal of medicinal chemistry.

MLA

Holzer Philipp, Masuya Keiichi, Furet Pascal, Kallen Joerg, Valat-Stachyra Therese, Ferretti Stéphane, Berghausen Joerg, Bouisset-Leonard Michèle, Buschmann Nicole, Pissot-Soldermann Carole, Rynn Caroline, Ruetz Stephan, Stutz Stefan, Chène Patrick, Jeay Sébastien and Gessier Francois. Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors. : Journal of medicinal chemistry. 20151116.